Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.49 |
| ▸ | ERN1 | O75460 | 2/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.37 |
| ▸ | MGAM | O43451 | 2/20 | 0.37 |
| ▸ | SI | P14410 | 2/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.36 |
| ▸ | TUBB | P07437 | 1/20 | 0.36 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16091526 | 0.81 | ACHE (0.59) | ACHEEPHX2ERN1MAPTCYP3A4 | |
| SCHEMBL7520392 | 0.78 | ERN1 (0.57) | ACHEERN1MAPTPTPN1GAA | |
| SCHEMBL4305857 | 0.76 | ACHE (0.54) | ACHEEPHX2MAPTATMCYP3A4 | |
| SCHEMBL16024748 | 0.75 | ERN1 (0.50) | ACHEEPHX2ERN1MAPTPTPN1 | |
| SCHEMBL18525393 | 0.75 | ERN1 (0.46) | ACHEERN1MAPTPIM1PTPN1 | |
| SCHEMBL890469 | 0.75 | ERN1 (0.46) | ACHEERN1MAPTCYP3A4PTPN1 | |
| SCHEMBL801089 | 0.73 | ERN1 (0.45) | ACHEERN1MAPTPIM1PTPN1 | |
| SCHEMBL29421891 | 0.73 | EPHX2 (0.57) | ACHEEPHX2ERN1MAPTATM | |
| SCHEMBL4472439 | 0.73 | EPHX2 (0.57) | ACHEEPHX2ERN1MAPTATM | |
| SCHEMBL17655758 | 0.72 | ACHE (0.76) | ACHEERN1MAPTCYP3A4TUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9771311-B2 | Coupling a phenol and an arene using selenium dioxide | EVONIK DEGUSSA GMBH (DE) | 2017-09-26 | — | — | US | disclosed |
| US-9771311-B2 | Coupling a phenol and an arene using selenium dioxide | EVONIK DEGUSSA GMBH (DE) | 2017-09-26 | — | — | US | disclosed |
| US-20160340281-A1 | COUPLING A PHENOL AND AN ARENE USING SELENIUM DIOXIDE | EVONIK DEGUSSA GMBH (DE) | 2016-11-24 | — | — | US | disclosed |
| US-20160340281-A1 | COUPLING A PHENOL AND AN ARENE USING SELENIUM DIOXIDE | EVONIK DEGUSSA GMBH (DE) | 2016-11-24 | — | — | US | disclosed |
| EP-3095776-A1 | Coupling of a phenol and an arene using selenium dioxide | Evonik Degussa GmbH (DE) | 2016-11-23 | — | — | EP | disclosed |
| US-8747646-B2 | Process for the anodic cross-dehydrodimerization of arenes | BASF SE (DE) | 2014-06-10 | — | — | US | disclosed |
| EP-2438214-B1 | METHOD FOR ANODIC CROSS-DEHYDRODIMERIZATION OF ARENES | BASF SE (DE) | 2013-05-29 | — | — | EP | disclosed |
| EP-2438214-A1 | METHOD FOR ANODIC CROSS-DEHYDRODIMERIZATION OF ARENES | BASF SE (DE) | 2012-04-11 | — | — | EP | disclosed |
| US-20120080320-A1 | PROCESS FOR THE ANODIC CROSS-DEHYDRODIMERIZATION OF ARENES | BASF SE (DE) | 2012-04-05 | — | — | US | disclosed |
| WO-2010139685-A1 | METHOD FOR ANODIC CROSS-DEHYDRODIMERIZATION OF ARENES | BASF SE (DE) | 2010-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160340281-A1 | COUPLING A PHENOL AND AN ARENE USING SELENIUM DIOXIDE | TYR, SCLY, SELENOI | ACHE 1678/4885EPHX2 164/4885ERN1 2115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.